Glaukos Announces Participation in the Piper Sandler Virtual Ophthalmology Symposium

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to virtually participate in the Piper Sandler Ophthalmology Symposium on Monday, May 23, 2022, at 2:00 p.m. ET. A live and archived webcast for this event will be available in the Investors section of the Glaukos websit

Full Story →